![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EMED Technologies Wins Expanded Indication for Syringe Infusion System
EMED Technologies Wins Expanded Indication for Syringe Infusion System
![](https://www.fdanews.com/ext/resources/test/Drug-Images/Pink-Syringe.gif?t=1495572842&width=430)
EMED Technologies has been granted expanded indications on its FDA-cleared SCIg60 infusion system.
The device administers human plasma-derived immunoglobulin biologics.
The SCIg60 relied upon drug-device compatibility validation for use, which includes subcutaneous infusions of Cuvitru, Gammagard liquid and Hizentra.
The FDA created a new device code “PKP” to classify and regulate infusion systems for immunoglobulins. — Cynthia Jessup
Upcoming Events
-
21Oct